Search
for
Sort by
Research 31–60 of 1000+
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Cronkhite-Canada syndrome: A rare disease presenting with dermatological and gastrointestinal manifestations
- Interventions for morphea
- Skin
- Anaesthetics and platelets.
- General Dermatology
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Manifestaciones dermatológicas en pacientes oncológicos pediátricos en un hospital de tercer nivel de Honduras
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- The use of oral recombinant feline interferon omega in two cats with type II diabetes mellitus and concurrent feline chronic gingivostomatitis syndrome
- Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- A 39‐year‐old woman with Lupus, Myositis, and a Recalcitrant Vasculopathy
- Acute Bullous Dermatosis and Onycholysis due to High-Dose Methotrexate and Leucovorin Calcium
- Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants
- A Case of 300 Pound Weight Loss, Malabsorption, Malnutrition and Protein Losing Enteropathy Due to Systemic Lupus Erythematosis of the Small Intestine
- Prophylaxis and Management of Skin Toxicities
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- 13. Wound Healing & Hair
- Photobiomodulation therapy
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Skin Pigmentation Types, Causes and Treatment—A Review
- Injectable Biomaterials for Dental Tissue Regeneration
- From Waste to Beauty: Agri-Food By-Products as Sources of Antioxidant Compounds for Cosmeceutical Applications
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY